Beta Bionics (BBNX) Income Statement: Revenue & Earnings

Beta Bionics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Beta Bionics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	65.12	12.00	0.18
Cost of Revenue	29.24	5.69	0.00
Gross Profit	35.89	6.31	0.18
Operating Expenses
Research & Development	26.18	17.94	31.43
Selling, General & Administrative	54.96	24.22	34.60
Operating Expenses	81.14	42.16	66.02
Operating Income	-45.25	-35.85	-65.84
Other Income/Expense
Interest Income	3.91	1.78	0.20
Interest Expense	0.00	0.07	0.01
Other Income/Expense	-9.51	-10.03	0.91
Income
Income Before Tax	-54.76	-44.10	-64.75
Income Tax Expense	0.00	0.00	0.00
Net Income	-54.76	-44.10	-64.75
Net Income - Continuous Operations	-54.76	-44.10	-64.75
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	-44.10	-33.76	-62.65
EBIT	-54.76	-35.85	-64.74
Depreciation & Amortization	1.15	2.09	2.09
Earnings Per Share
Basic EPS	-9.00	-1.00	-2.00
Diluted EPS	-9.00	-1.00	-2.00
Basic Shares Outstanding	6.37	30.50	30.50
Diluted Shares Outstanding	6.37	30.50	30.50